Definitely. At CIHR we have a lot of programs in partnership with pharmaceutical companies. They bring in a lot of dollars, and through CIHR all the dollars are unconditional. They are actually co-funding that whole network about getting research in Alzheimer's disease into action. It's not just about whether this drug works well but also about non-pharmaceutical therapies that are being tested in that network. We conducted regional senior workshops across the country with just seniors and seniors organizations, and they sponsored supporting the cost of that because we paid the way for all the seniors. So yes, it can be perceived as conflict, but we have ways internally to manage.
On January 31st, 2008. See this statement in context.